NO20075997L - Methoder til furifysering av tigecyklin - Google Patents

Methoder til furifysering av tigecyklin

Info

Publication number
NO20075997L
NO20075997L NO20075997A NO20075997A NO20075997L NO 20075997 L NO20075997 L NO 20075997L NO 20075997 A NO20075997 A NO 20075997A NO 20075997 A NO20075997 A NO 20075997A NO 20075997 L NO20075997 L NO 20075997L
Authority
NO
Norway
Prior art keywords
methods
tigecycline
furphysing
preparations
tetracyclines
Prior art date
Application number
NO20075997A
Other languages
English (en)
Inventor
Phaik-Eng Sum
Sylvain Daigneault
Michel Bernatchez
Anthony Scott Pilcher
Lalitha Krishnan
Jeffrey Marshall Horne
Adam Joseph Tuper
Iii Joseph James Mccauley
Adam P Michaud
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36997702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075997(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20075997L publication Critical patent/NO20075997L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Det er beskrevet metoder for fremstilling og rensing av tetrasykliner, så som tigesyklin. Det er også beskrevet tetrasyklin-preparater, så som tigesyklin-preparater, som er fremstilt ved disse metodene. Fig.1 Fig. 1
NO20075997A 2005-05-27 2007-11-23 Methoder til furifysering av tigecyklin NO20075997L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68562605P 2005-05-27 2005-05-27
PCT/US2006/020270 WO2006130431A1 (en) 2005-05-27 2006-05-25 Methods of purifying tigecycline

Publications (1)

Publication Number Publication Date
NO20075997L true NO20075997L (no) 2008-02-19

Family

ID=36997702

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075997A NO20075997L (no) 2005-05-27 2007-11-23 Methoder til furifysering av tigecyklin

Country Status (22)

Country Link
US (1) US20070049561A1 (no)
EP (1) EP1890997A1 (no)
JP (1) JP2008545702A (no)
KR (1) KR20080016892A (no)
CN (1) CN101228114A (no)
AR (1) AR057034A1 (no)
AU (1) AU2006252796A1 (no)
BR (1) BRPI0610057A2 (no)
CA (1) CA2609307A1 (no)
CR (1) CR9542A (no)
EC (1) ECSP078050A (no)
GT (1) GT200600224A (no)
IL (1) IL187361A0 (no)
MX (1) MX2007014717A (no)
NI (1) NI200700302A (no)
NO (1) NO20075997L (no)
PA (1) PA8676401A1 (no)
PE (1) PE20070318A1 (no)
RU (1) RU2007143158A (no)
TW (1) TW200716516A (no)
WO (1) WO2006130431A1 (no)
ZA (1) ZA200710174B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101354093B1 (ko) 2005-03-14 2014-01-24 와이어쓰 엘엘씨 티게사이클린 조성물 및 이의 제조방법
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
AR055336A1 (es) 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
CA2649221A1 (en) * 2006-04-17 2007-10-25 Evgeny Tsiperman Isolation of tetracycline derivatives
PL2016045T3 (pl) 2006-04-24 2015-04-30 Teva Pharma Krystaliczna postać tygecykliny i sposoby jej otrzymywania
US8198470B2 (en) 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
US8198469B2 (en) 2006-11-29 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of tigecycline and processes for preparation thereof
EP2084126A1 (en) * 2006-11-30 2009-08-05 Teva Pharmaceutical Industries Ltd. Processes for preparation of 9-haloacetamidominocyclines
US20080214869A1 (en) * 2007-03-01 2008-09-04 Sergei Fine Processes for purification of tigecycline
EP2144870A2 (en) * 2007-04-27 2010-01-20 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
US20100160264A1 (en) * 2007-06-21 2010-06-24 Josef Wieser Crystalline solid forms
WO2009052152A2 (en) * 2007-10-16 2009-04-23 Wyeth Tigecycline and methods of preparing intermediates
CN101861300B (zh) 2007-11-14 2014-07-09 桑多斯股份公司 盐酸替吉环素的晶型
CN101450916B (zh) * 2007-11-30 2012-11-21 上海来益生物药物研究开发中心有限责任公司 替加环素的合成方法
US20110124893A1 (en) * 2008-01-23 2011-05-26 Sandoz Ag Antibiotic compounds
CA2746585C (en) 2008-12-18 2017-08-29 Sandoz Ag Crystalline form c of tigecycline dihydrochloride and methods for its preparation
EP2406213A1 (en) 2009-03-12 2012-01-18 Wyeth LLC Nitration of tetracyclines
PL2327676T3 (pl) * 2009-11-26 2014-08-29 Sandoz Ag Reakcja związków organicznych z małymi ilościami wodoru
CN102898325B (zh) * 2011-07-29 2015-07-08 江苏奥赛康药业股份有限公司 替加环素晶体及其制备方法
CN102952035A (zh) * 2011-09-15 2013-03-06 北京海步国际医药科技发展有限公司 替加环素新晶型及其制备方法
CN103091424B (zh) * 2013-01-31 2014-11-19 成都百裕科技制药有限公司 替加环素中杂质的检测方法
CN104515820B (zh) * 2013-10-06 2018-08-14 山东新时代药业有限公司 一种替加环素中间体的分析检测方法
US20160143925A1 (en) 2013-11-12 2016-05-26 Galenicum Health S.L. Stable pharmaceutical compositions
PT108223B (pt) * 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
CN105085311A (zh) * 2015-08-13 2015-11-25 江苏豪森药业股份有限公司 替加环素或其盐的高效纯化方法
CN107304173A (zh) * 2016-04-25 2017-10-31 浙江医药股份有限公司新昌制药厂 一种替加环素的晶型及其制备方法
CN111978196A (zh) * 2020-08-03 2020-11-24 河北圣雪大成制药有限责任公司 一种替加环素的纯化方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE26271E (en) * 1967-09-26 Reductive alkylation process
US3502696A (en) * 1961-08-18 1970-03-24 Pfizer & Co C Antibacterial agents
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3433834A (en) * 1966-03-14 1969-03-18 American Cyanamid Co Nitration of 11a-chloro tetracyclines
US3849493A (en) * 1966-08-01 1974-11-19 Pfizer D-ring substituted 6-deoxytetracyclines
US3518306A (en) * 1968-02-19 1970-06-30 American Cyanamid Co 7- and/or 9-(n-nitrosoalkylamino)-6-demethyl-6-deoxytetracyclines
US3579579A (en) * 1968-04-18 1971-05-18 American Cyanamid Co Substituted 7- and/or 9-amino-6-demethyl-6-deoxytetracyclines
US4038315A (en) * 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
US5202449A (en) * 1987-07-28 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for purifying 7-dimethylamino-6-demethyl-6-deoxytetracycline
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5281628A (en) * 1991-10-04 1994-01-25 American Cyanamid Company 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) * 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
SG47520A1 (en) * 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5248797A (en) * 1992-08-13 1993-09-28 American Cyanamid Company Method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5442059A (en) * 1992-08-13 1995-08-15 American Cyanamid Company 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
US5371076A (en) * 1993-04-02 1994-12-06 American Cyanamid Company 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
US5834450A (en) * 1994-02-17 1998-11-10 Pfizer Inc. 9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5675030A (en) * 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
US5843925A (en) * 1994-12-13 1998-12-01 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
US6818635B2 (en) * 2000-07-07 2004-11-16 Paratek Pharmaceuticals, Inc. 7-substituted tetracycline compounds

Also Published As

Publication number Publication date
CN101228114A (zh) 2008-07-23
GT200600224A (es) 2007-01-12
IL187361A0 (en) 2008-04-13
BRPI0610057A2 (pt) 2010-05-25
NI200700302A (es) 2008-07-24
CA2609307A1 (en) 2006-12-07
US20070049561A1 (en) 2007-03-01
CR9542A (es) 2008-02-20
ECSP078050A (es) 2008-01-23
TW200716516A (en) 2007-05-01
PA8676401A1 (es) 2009-03-31
PE20070318A1 (es) 2007-04-11
KR20080016892A (ko) 2008-02-22
WO2006130431A1 (en) 2006-12-07
MX2007014717A (es) 2008-02-15
JP2008545702A (ja) 2008-12-18
ZA200710174B (en) 2009-08-26
RU2007143158A (ru) 2009-07-10
EP1890997A1 (en) 2008-02-27
AR057034A1 (es) 2007-11-14
AU2006252796A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
NO20075997L (no) Methoder til furifysering av tigecyklin
NO20076072L (no) Tigecyklin og metoder for fremstilling av 9-nitrominocyklin
NO20076001L (no) Tigecyklin og metoder for deres fremstilling
NO20075998L (no) Tigecyklin og metoder til fremstilling av 9-aminominocyklin
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
NO20081042L (no) PPAR aktive forbindelser
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
EA200802365A1 (ru) Аминометилзамещенные тетрациклиновые соединения
NO20065329L (no) Fremstilling av pregabalin og beslektede forbindelser.
CY1114916T1 (el) Μεθοδοι
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
TW200720232A (en) Crystalline solid forms of tigecycline and methods of preparing same
DK1913001T3 (da) (r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
NO20055026L (no) Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse
EA200702586A1 (ru) Кристаллические модификации пираклостробина
DK1414809T3 (da) Indaneddikesyrederivater og anvendelse deraf som farmaceutiske midler, mellemprodukter og fremgangsmåder til fremstilling deraf
NO20064034L (no) Makrolider og fremgangsmater for a fremstille disse
EA200801414A1 (ru) Кальцилитические соединения
WO2008045507A3 (en) Substituted tetracycline compounds for treatment of bacillus anthracis infections
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application